Knotus Co Ltd
KOSDAQ:278650
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Knotus Co Ltd
KOSDAQ:278650
|
KR |
|
Hichain Logistics Co Ltd
SZSE:300873
|
CN |
|
Potlatchdeltic Corp
NASDAQ:PCH
|
US |
|
Zhejiang Lante Optics Co Ltd
SSE:688127
|
CN |
|
Tilray Brands Inc
XETRA:2HQ0
|
CA |
|
Z
|
Zhefu Holding Group Co Ltd
SZSE:002266
|
CN |
|
Verona Pharma PLC
NASDAQ:VRNA
|
UK |
|
P
|
Pharmedic Pharmaceutical Medicinal JSC
VN:PMC
|
VN |
Knotus Co Ltd
KNOTUS Co. Ltd. engages in the provision of clinical research services. The company is headquartered in Incheon, Incheon. The company went IPO on 2019-11-27. is a Korea-based company principally engaged in the nonclinical experiment business. Along with subsidiaries, the Company operates its business through three segments. The Nonclinical Contract Research Organization (CRO) Business segment conducts nonclinical experiments on new developed substances such as new drugs, and tests the efficacy and pharmacodynamics of the substances. This segment also provides services including new drug development related equipment, software and analysis of experimental results. The Animal Laboratory Construction Business segment is engaged in the construction and design of animal laboratories and the supply of reagent consumables. The Pet Business segment is engaged in the development of animal medicines and the sale of pet supplies.
KNOTUS Co. Ltd. engages in the provision of clinical research services. The company is headquartered in Incheon, Incheon. The company went IPO on 2019-11-27. is a Korea-based company principally engaged in the nonclinical experiment business. Along with subsidiaries, the Company operates its business through three segments. The Nonclinical Contract Research Organization (CRO) Business segment conducts nonclinical experiments on new developed substances such as new drugs, and tests the efficacy and pharmacodynamics of the substances. This segment also provides services including new drug development related equipment, software and analysis of experimental results. The Animal Laboratory Construction Business segment is engaged in the construction and design of animal laboratories and the supply of reagent consumables. The Pet Business segment is engaged in the development of animal medicines and the sale of pet supplies.
